Literature DB >> 16414123

A role for Fas-Fas ligand interactions during the late-stage neuropathological processes of experimental cerebral malaria.

Sarah M Potter1, Tailoi Chan-Ling, Emilia Rosinova, Helen J Ball, Andrew J Mitchell, Nicholas H Hunt.   

Abstract

Cerebral malaria (CM) kills more than 1 million children each year. Using a murine model of CM, we investigated the role of Fas-Fas ligand interactions in the neuropathogenesis of this disease. Lpr and Gld mice, deficient in Fas and Fas ligand, respectively, were protected from fatal CM, although they demonstrated some pathological features associated with CM in the wild type mouse. Fas-Fas ligand mRNA and protein expression were increased in the brain in mice with CM, and activated caspase-3-positive apoptotic astrocytes were observed. We suggest that Fas-mediated apoptosis of astrocytes is likely to be a critical factor in late-stage murine CM pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16414123     DOI: 10.1016/j.jneuroim.2005.12.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  17 in total

Review 1.  Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.

Authors:  Sabrina Torre; David Langlais; Philippe Gros
Journal:  Mamm Genome       Date:  2018-06-19       Impact factor: 2.957

2.  Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria.

Authors:  Fiona E Lovegrove; Sina A Gharib; Samir N Patel; Cheryl A Hawkes; Kevin C Kain; W Conrad Liles
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

3.  Apoptosis induced by parasitic diseases.

Authors:  Anne-Lise Bienvenu; Elena Gonzalez-Rey; Stephane Picot
Journal:  Parasit Vectors       Date:  2010-11-17       Impact factor: 3.876

4.  Predominance of interferon-related responses in the brain during murine malaria, as identified by microarray analysis.

Authors:  Jenny Miu; Nicholas H Hunt; Helen J Ball
Journal:  Infect Immun       Date:  2008-02-25       Impact factor: 3.441

Review 5.  Glial activation and matrix metalloproteinase release in cerebral malaria.

Authors:  A Szklarczyk; M Stins; E A Milward; H Ryu; C Fitzsimmons; D Sullivan; K Conant
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

Review 6.  Genetic polymorphisms linked to susceptibility to malaria.

Authors:  Adel Driss; Jacqueline M Hibbert; Nana O Wilson; Shareen A Iqbal; Thomas V Adamkiewicz; Jonathan K Stiles
Journal:  Malar J       Date:  2011-09-19       Impact factor: 2.979

Review 7.  Dysregulation of coagulation in cerebral malaria.

Authors:  Christopher Alan Moxon; Robert Simon Heyderman; Samuel Crocodile Wassmer
Journal:  Mol Biochem Parasitol       Date:  2009-03-26       Impact factor: 1.759

8.  Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria.

Authors:  Nana O Wilson; Wesley Solomon; Leonard Anderson; John Patrickson; Sidney Pitts; Vincent Bond; Mingli Liu; Jonathan K Stiles
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

9.  Self-reactivities to the non-erythroid alpha spectrin correlate with cerebral malaria in Gabonese children.

Authors:  Vincent Guiyedi; Youri Chanseaud; Constantin Fesel; Georges Snounou; Jean-Claude Rousselle; Pharat Lim; Jean Koko; Abdelkader Namane; Pierre-André Cazenave; Maryvonne Kombila; Sylviane Pied
Journal:  PLoS One       Date:  2007-04-25       Impact factor: 3.240

10.  Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children.

Authors:  Henry B Armah; Nana O Wilson; Bismark Y Sarfo; Michael D Powell; Vincent C Bond; Winston Anderson; Andrew A Adjei; Richard K Gyasi; Yao Tettey; Edwin K Wiredu; Jon Eric Tongren; Venkatachalam Udhayakumar; Jonathan K Stiles
Journal:  Malar J       Date:  2007-11-12       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.